Figure 3.

Blood immune cell and cytokine outcomes. White blood cells (A), lymphocytes (B), neutrophils (C), monocytes (D), and eosinophils (E) were determined by the automated method in blood samples collected at inclusion and discharge. Interleukin-1 beta (F) and interleukin-6 were determined using ELISA kits in serum samples collected at inclusion and discharge. Dsc, discharge; iC1e/K, inhibitor of C1 esterase/kallikrein; IL-1b, interleukin-1 beta; IL-6, interleukin-6; Incl, inclusion; SC, standard care. Non-parametric Wilcoxon test was used for comparisons between pre- and post-intervention (A–G). Results are presented as mean ± standard deviation. * p < 0.05.